Associated Skin Care Specialists

Fridley, Minnesota 55432

0 studies enrolling now · 3 studies all time

What they study most

Allergic Contact Dermatitis, Atopic Dermatitis

Studies at this site

• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed
• Evaluation of EB01 Cream for the Treatment of Chronic Allergic Contact Dermatitis — Completed
• Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis — Completed